Brief profiles of these recently formed companies: 480 Biomedical, Alafair Biosciences, Blaze Bioscience and Oncobiologics
480 Arsenal StreetWatertown, MA 02172
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
Relaxing CAR-T restrictions may not be an access panacea because of patient fragility and lack of payer incentive. Conversely, the ACIP’s recent recommendation on Thiomersal-containing flu vaccines is probably the thin edge of a more restrictive wedge.
Coartem Baby to be rolled out in eight African countries in the autumn.
Apogee Therapeutics reports data from Phase II APEX trial of its long-acting antibody against atopic dermatitis, showing similar efficacy to Regeneron/Sanofi’s Dupixent and Eli Lilly’s Ebglyss.
